1. |
Castro SM, Pesqueira FP, Carmen GFM, et al. Pseudohypoparathyroidism: an example of multihormonal resistance. Endocrinol Nutr, 2009, 56(10): 461-462.
|
2. |
Bastepe M, Juppner H. GNAS locus and pseudohypoparathyroidism. Horm Res, 2005, 63(2): 65-74.
|
3. |
Mantovani G, Spada A, Elli FM. Pseudohypoparathyroidism and Gsalpha-cAMP-linked disorders: current view and open issues. Nat Rev Endocrinol, 2016, 12(6): 347-356.
|
4. |
Mantovani G, Bastepe M, Monk D, et al. Diagnosis and management of pseudohypoparathyroidism and related disorders: first international Consensus Statement. Nat Rev Endocrinol, 2018, 14(8): 476-500.
|
5. |
Mantovani G, Bondioni S, Linglart A, et al. Genetic analysis and evaluation of resistance to thyrotropin and growth hormone-releasing hormone in pseudohypoparathyroidism type Ib. J Clin Endocrinol Metab, 2007, 92(9): 3738-3742.
|
6. |
Rodriguez HJ, Villarreal HJ, Klahr S, et al. Pseudohypoparathyroidism type II: restoration of normal renal responsiveness to parathyroid hormone by calcium administration. J Clin Endocrinol Metab, 1974, 39(4): 693-701.
|
7. |
Rao DS, Parfitt AM, Kleerekoper M, et al. Dissociation between the effects of endogenous parathyroid hormone on adenosine 3', 5'-monophosphate generation and phosphate reabsorption in hypocalcemia due to vitamin D depletion: an acquired disorder resembling pseudohypoparathyroidism type II. J Clin Endocrinol Metab, 1985, 61(2): 285-290.
|
8. |
Lu D, Dong A, Zhang J, et al. A novel GNAS mutation in pseudohypoparathyroidism type 1a in a Chinese man presented with recurrent seizure: a case report. BMC Endocr Disord, 2021, 21(1): 12.
|
9. |
Kim Y S, Park J, Park Y, et al. Intracranial cortical calcifications in a focal epilepsy patient with pseudohypoparathyroidism. J Epilepsy Res, 2016, 6(1): 31-35.
|
10. |
Wang Y, Xu C, Xu Z, et al. Depolarized GABAergic signaling in subicular microcircuits mediates generalized seizure in temporal lobe epilepsy. Neuron, 2017, 95(1): 92-105.
|
11. |
Hahn TJ. Drug-induced disorders of vitamin D and mineral metabolism. Clin Endocrinol Metab, 1980, 9(1): 107-127.
|
12. |
Lemos MC, Thakker RV. GNAS mutations in Pseudohypoparathyroidism type 1a and related disorders. Hum Mutat, 2015, 36(1): 11-19.
|
13. |
Srivastava S, Engels H, Schanze I, et al. Loss-of-function variants in HIVEP2 are a cause of intellectual disability. Eur J Hum Genet, 2016, 24(4): 556-561.
|